GSK and Med­ica­go have glob­al plans for their Covid-19 vac­cine. But WHO balks at Big To­bac­co in­vestor

Over the last cou­ple years, Glax­o­SmithK­line lent its ad­ju­vant tech­nol­o­gy to sev­er­al ex­per­i­men­tal Covid-19 vac­cines, and last month, the Cana­di­an gov­ern­ment fi­nal­ly came through with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER